Premium
Potential New Indication for Ivabradine: Treatment of a Patient with Congenital Junctional Ectopic Tachycardia
Author(s) -
ALGHAMDI SALEH,
ALFAYYADH MAJID I.,
HAMILTON ROBERT M.
Publication year - 2013
Publication title -
journal of cardiovascular electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.193
H-Index - 138
eISSN - 1540-8167
pISSN - 1045-3873
DOI - 10.1111/jce.12081
Subject(s) - ivabradine , medicine , cardiology , tachycardia , heart rate , blood pressure
Potential New Indication for Ivabradine Ivabradine is a new antiarrhythmic agent with direct inhibition of the pacemaker (If) current. It has been used extensively to decrease sinus rate in the treatment of cardiac failure, and also in a single case of atrial ectopic tachycardia in a child. Here we report the case of a 3‐year‐old girl with congenital junctional ectopic tachycardia (JET), resistant to conventional antiarrhythmic medications, who was successfully treated with ivabradine. We suggest that ivabradine can be an effective treatment for junctional automatic tachycardias and can be considered as a new line of therapy for this incessant form of tachycardia.